ID KCNV2_HUMAN Reviewed; 545 AA. AC Q8TDN2; Q5T6X0; DT 28-NOV-2002, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2002, sequence version 1. DT 24-JAN-2024, entry version 174. DE RecName: Full=Potassium voltage-gated channel subfamily V member 2; DE AltName: Full=Voltage-gated potassium channel subunit Kv8.2; GN Name=KCNV2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], SUBUNIT, AND TISSUE SPECIFICITY. RC TISSUE=Brain; RX PubMed=12060745; DOI=10.1073/pnas.122617999; RA Ottschytsch N., Raes A., Van Hoorick D., Snyders D.J.; RT "Obligatory heterotetramerization of three previously uncharacterized Kv RT channel alpha-subunits identified in the human genome."; RL Proc. Natl. Acad. Sci. U.S.A. 99:7986-7991(2002). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164053; DOI=10.1038/nature02465; RA Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., RA Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., RA Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., RA Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., RA Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y., RA Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., RA Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E., RA Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M., RA Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J., RA Frankish A., Frankland J.A., French L., Fricker D.G., Garner P., RA Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S., RA Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E., RA Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D., RA Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E., RA Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K., RA Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S., RA Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J., RA Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E., RA McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V., RA Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S., RA Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K., RA Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J., RA Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., RA West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L., RA Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M., RA Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J., RA Dunham I.; RT "DNA sequence and analysis of human chromosome 9."; RL Nature 429:369-374(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP VARIANTS RCD3B GLN-126; CYS-188; TRP-256; VAL-259; 339-ASP--VAL-341 DEL AND RP ASP-459, AND VARIANT VAL-533. RX PubMed=16909397; DOI=10.1086/507568; RA Wu H., Cowing J.A., Michaelides M., Wilkie S.E., Jeffery G., Jenkins S.A., RA Mester V., Bird A.C., Robson A.G., Holder G.E., Moore A.T., Hunt D.M., RA Webster A.R.; RT "Mutations in the gene KCNV2 encoding a voltage-gated potassium channel RT subunit cause 'cone dystrophy with supernormal rod electroretinogram' in RT humans."; RL Am. J. Hum. Genet. 79:574-579(2006). RN [5] RP VARIANT RCD3B PRO-244, CHARACTERIZATION OF VARIANT RCD3B PRO-244, AND RP INTERACTION WITH KCNB1. RX PubMed=34535971; DOI=10.1002/mgg3.1795; RA Liu M., Zhu Y., Huang L., Jiang W., Wu N., Song Y., Lu Y., Ma Y.; RT "Compound heterozygous KCNV2 variants contribute to cone dystrophy with RT supernormal rod responses in a Chinese family."; RL Mol. Genet. Genomic Med. 9:e1795-e1795(2021). CC -!- FUNCTION: Potassium channel subunit. Modulates channel activity by CC shifting the threshold and the half-maximal activation to more negative CC values. CC -!- SUBUNIT: Heteromultimer with KCNB1, KCNC1 and KCNF1. Does not form CC homomultimers. {ECO:0000269|PubMed:12060745, CC ECO:0000269|PubMed:34535971}. CC -!- INTERACTION: CC Q8TDN2; O15084: ANKRD28; NbExp=3; IntAct=EBI-12014650, EBI-359567; CC -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. CC Note=Has to be associated with KCNB1 or possibly another partner to get CC inserted in the plasma membrane. Remains intracellular in the absence CC of KCNB1. CC -!- TISSUE SPECIFICITY: Detected in lung, liver, kidney, pancreas, spleen, CC thymus, prostate, testis, ovary and colon. CC {ECO:0000269|PubMed:12060745}. CC -!- DOMAIN: The segment S4 is probably the voltage-sensor and is CC characterized by a series of positively charged amino acids at every CC third position. CC -!- DISEASE: Cone dystrophy retinal 3B (RCD3B) [MIM:610356]: A rare form of CC cone dystrophy associated with supernormal rod responses. The disorder CC is characterized by reduced visual acuity, photoaversion, night CC blindness, and abnormal color vision. At an early age, the retina shows CC subtle depigmentation at the macula and, later, more obvious areas of CC atrophy. {ECO:0000269|PubMed:16909397, ECO:0000269|PubMed:34535971}. CC Note=The disease is caused by variants affecting the gene represented CC in this entry. CC -!- SIMILARITY: Belongs to the potassium channel family. V (TC 1.A.1.2) CC subfamily. Kv8.2/KCNV2 sub-subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF348983; AAL83910.1; -; mRNA. DR EMBL; AL354723; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC101352; AAI01353.1; -; mRNA. DR EMBL; BC101353; AAI01354.1; -; mRNA. DR CCDS; CCDS6447.1; -. DR RefSeq; NP_598004.1; NM_133497.3. DR AlphaFoldDB; Q8TDN2; -. DR SMR; Q8TDN2; -. DR BioGRID; 127982; 16. DR IntAct; Q8TDN2; 4. DR STRING; 9606.ENSP00000371514; -. DR ChEMBL; CHEMBL2362996; -. DR DrugBank; DB00228; Enflurane. DR DrugBank; DB01110; Miconazole. DR DrugBank; DB01069; Promethazine. DR DrugCentral; Q8TDN2; -. DR TCDB; 1.A.1.2.23; the voltage-gated ion channel (vic) superfamily. DR TCDB; 1.A.1.2.24; the voltage-gated ion channel (vic) superfamily. DR GlyCosmos; Q8TDN2; 1 site, No reported glycans. DR GlyGen; Q8TDN2; 3 sites, 1 O-linked glycan (2 sites). DR iPTMnet; Q8TDN2; -. DR PhosphoSitePlus; Q8TDN2; -. DR BioMuta; KCNV2; -. DR DMDM; 26006804; -. DR MassIVE; Q8TDN2; -. DR PaxDb; 9606-ENSP00000371514; -. DR PeptideAtlas; Q8TDN2; -. DR ProteomicsDB; 74309; -. DR Antibodypedia; 23918; 254 antibodies from 25 providers. DR DNASU; 169522; -. DR Ensembl; ENST00000382082.4; ENSP00000371514.3; ENSG00000168263.9. DR GeneID; 169522; -. DR KEGG; hsa:169522; -. DR MANE-Select; ENST00000382082.4; ENSP00000371514.3; NM_133497.4; NP_598004.1. DR UCSC; uc003zho.3; human. DR AGR; HGNC:19698; -. DR CTD; 169522; -. DR DisGeNET; 169522; -. DR GeneCards; KCNV2; -. DR HGNC; HGNC:19698; KCNV2. DR HPA; ENSG00000168263; Tissue enriched (retina). DR MalaCards; KCNV2; -. DR MIM; 607604; gene. DR MIM; 610356; phenotype. DR neXtProt; NX_Q8TDN2; -. DR OpenTargets; ENSG00000168263; -. DR Orphanet; 209932; Cone dystrophy with supernormal rod response. DR PharmGKB; PA134992655; -. DR VEuPathDB; HostDB:ENSG00000168263; -. DR eggNOG; KOG3713; Eukaryota. DR GeneTree; ENSGT00940000157438; -. DR HOGENOM; CLU_011722_4_1_1; -. DR InParanoid; Q8TDN2; -. DR OMA; YQAVAIY; -. DR OrthoDB; 1478695at2759; -. DR PhylomeDB; Q8TDN2; -. DR TreeFam; TF313103; -. DR PathwayCommons; Q8TDN2; -. DR Reactome; R-HSA-1296072; Voltage gated Potassium channels. DR SignaLink; Q8TDN2; -. DR BioGRID-ORCS; 169522; 13 hits in 1141 CRISPR screens. DR ChiTaRS; KCNV2; human. DR GeneWiki; KCNV2; -. DR GenomeRNAi; 169522; -. DR Pharos; Q8TDN2; Tclin. DR PRO; PR:Q8TDN2; -. DR Proteomes; UP000005640; Chromosome 9. DR RNAct; Q8TDN2; Protein. DR Bgee; ENSG00000168263; Expressed in sperm and 53 other cell types or tissues. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0008076; C:voltage-gated potassium channel complex; IBA:GO_Central. DR GO; GO:0005249; F:voltage-gated potassium channel activity; IBA:GO_Central. DR GO; GO:0071805; P:potassium ion transmembrane transport; IBA:GO_Central. DR GO; GO:0051260; P:protein homooligomerization; IEA:InterPro. DR Gene3D; 1.10.287.70; -; 1. DR Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 1. DR InterPro; IPR005821; Ion_trans_dom. DR InterPro; IPR003968; K_chnl_volt-dep_Kv. DR InterPro; IPR003971; K_chnl_volt-dep_Kv9. DR InterPro; IPR011333; SKP1/BTB/POZ_sf. DR InterPro; IPR003131; T1-type_BTB. DR InterPro; IPR027359; Volt_channel_dom_sf. DR PANTHER; PTHR11537:SF40; POTASSIUM VOLTAGE-GATED CHANNEL SUBFAMILY V MEMBER 2; 1. DR PANTHER; PTHR11537; VOLTAGE-GATED POTASSIUM CHANNEL; 1. DR Pfam; PF02214; BTB_2; 1. DR Pfam; PF00520; Ion_trans; 1. DR PRINTS; PR00169; KCHANNEL. DR PRINTS; PR01494; KV9CHANNEL. DR PRINTS; PR01491; KVCHANNEL. DR SUPFAM; SSF54695; POZ domain; 1. DR SUPFAM; SSF81324; Voltage-gated potassium channels; 1. DR Genevisible; Q8TDN2; HS. PE 1: Evidence at protein level; KW Cell membrane; Cone-rod dystrophy; Disease variant; Glycoprotein; KW Ion channel; Ion transport; Membrane; Potassium; Potassium channel; KW Potassium transport; Reference proteome; Transmembrane; KW Transmembrane helix; Transport; Voltage-gated channel. FT CHAIN 1..545 FT /note="Potassium voltage-gated channel subfamily V member FT 2" FT /id="PRO_0000054094" FT TOPO_DOM 1..155 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 156..176 FT /note="Helical; Name=Segment S1" FT /evidence="ECO:0000255" FT TOPO_DOM 177..261 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 262..282 FT /note="Helical; Name=Segment S2" FT /evidence="ECO:0000255" FT TOPO_DOM 283..336 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 337..357 FT /note="Helical; Name=Segment S3" FT /evidence="ECO:0000255" FT TOPO_DOM 358..374 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 375..395 FT /note="Helical; Voltage-sensor; Name=Segment S4" FT /evidence="ECO:0000255" FT TOPO_DOM 396..410 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 411..431 FT /note="Helical; Name=Segment S5" FT /evidence="ECO:0000255" FT TOPO_DOM 432..444 FT /note="Extracellular" FT /evidence="ECO:0000255" FT INTRAMEM 445..465 FT /note="Pore-forming; Name=Segment H5" FT /evidence="ECO:0000255" FT TOPO_DOM 466..471 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 472..492 FT /note="Helical; Name=Segment S6" FT /evidence="ECO:0000255" FT TOPO_DOM 493..545 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REGION 74..93 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 457..462 FT /note="Selectivity filter" FT /evidence="ECO:0000250" FT CARBOHYD 440 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VARIANT 126 FT /note="L -> Q (in RCD3B; dbSNP:rs776275880)" FT /evidence="ECO:0000269|PubMed:16909397" FT /id="VAR_027632" FT VARIANT 188 FT /note="W -> C (in RCD3B; dbSNP:rs772921412)" FT /evidence="ECO:0000269|PubMed:16909397" FT /id="VAR_027633" FT VARIANT 244 FT /note="R -> P (in RCD3B; loss of interaction with KCNB1; FT dbSNP:rs1023306854)" FT /evidence="ECO:0000269|PubMed:34535971" FT /id="VAR_087564" FT VARIANT 256 FT /note="S -> W (in RCD3B; dbSNP:rs104894116)" FT /evidence="ECO:0000269|PubMed:16909397" FT /id="VAR_027634" FT VARIANT 259 FT /note="A -> V (in RCD3B)" FT /evidence="ECO:0000269|PubMed:16909397" FT /id="VAR_027635" FT VARIANT 339..341 FT /note="Missing (in RCD3B)" FT /evidence="ECO:0000269|PubMed:16909397" FT /id="VAR_027636" FT VARIANT 459 FT /note="G -> D (in RCD3B; dbSNP:rs104894115)" FT /evidence="ECO:0000269|PubMed:16909397" FT /id="VAR_027637" FT VARIANT 533 FT /note="L -> V (in dbSNP:rs12352254)" FT /evidence="ECO:0000269|PubMed:16909397" FT /id="VAR_027638" SQ SEQUENCE 545 AA; 62459 MW; 72D175B4C0C6B1DA CRC64; MLKQSERRRS WSYRPWNTTE NEGSQHRRSI CSLGARSGSQ ASIHGWTEGN YNYYIEEDED GEEEDQWKDD LAEEDQQAGE VTTAKPEGPS DPPALLSTLN VNVGGHSYQL DYCELAGFPK TRLGRLATST SRSRQLSLCD DYEEQTDEYF FDRDPAVFQL VYNFYLSGVL LVLDGLCPRR FLEELGYWGV RLKYTPRCCR ICFEERRDEL SERLKIQHEL RAQAQVEEAE ELFRDMRFYG PQRRRLWNLM EKPFSSVAAK AIGVASSTFV LVSVVALALN TVEEMQQHSG QGEGGPDLRP ILEHVEMLCM GFFTLEYLLR LASTPDLRRF ARSALNLVDL VAILPLYLQL LLECFTGEGH QRGQTVGSVG KVGQVLRVMR LMRIFRILKL ARHSTGLRAF GFTLRQCYQQ VGCLLLFIAM GIFTFSAAVY SVEHDVPSTN FTTIPHSWWW AAVSISTVGY GDMYPETHLG RFFAFLCIAF GIILNGMPIS ILYNKFSDYY SKLKAYEYTT IRRERGEVNF MQRARKKIAE CLLGSNPQLT PRQEN //